Although it is treatable, it’s not considered to be curable. In the early stages, CLL often doesn't require treatment immediately, as studies have shown that early treatment doesn’t increase ...

But when CLL crowds out the healthy cells in your bone marrow and you get symptoms, you may need treatment. That’s what happened to Larry Saltzman, MD, a retired family doctor in Sacramento ...

This represents a challenging duty for physicians treating CLL patients in the day-to-day practice. What is clear is that any method of measuring fitness in CLL patients must be simple and easy to ...

If your CLL is in the early stages, you may not need treatment right away. If you do, your treatment will depend on your cancer stage, symptoms, total health, and preferences. Treatment options ...

Chronic lymphocytic leukemia (CLL) is a type of cancer affecting a type of white blood cell in the blood and bone marrow. It often progresses slowly and is diagnosed most often during routine ...

Panelists discuss how challenges in implementing emerging Bruton tyrosine kinase inhibitor (BTKi) regimens for ...

During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed treatment for a patient with chronic ...

The study noted that people with skin cancer and CLL were also more likely to develop other cancers. Treating CLL with a tyrosine kinase inhibitor (TKI) drug called ibrutinib seemed to reduce the ...

1,3 The campaign is anchored by a real patient’s journey with CLL and how his experience with testing before treatment helped him select a treatment that offered a potentially better outcome.

The incidence of chronic lymphocytic leukemia (CLL) is dramatically increased in elderly patients although knowledge on how to treat them in day-to-day practice is still incomplete. Moreover ...

"While scientific advancements have significantly expanded treatment options for people with CLL, too many patients do not receive the therapies that will work best for them based on their unique ...